These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33513656)
21. Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse drug reaction. Kuntzen T; Friedrichs N; Fischer HP; Eis-Hübinger AM; Sauerbruch T; Spengler U Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1131-4. PubMed ID: 16148562 [TBL] [Abstract][Full Text] [Related]
22. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review. Kerkar N; Yanni G J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632 [TBL] [Abstract][Full Text] [Related]
23. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783 [TBL] [Abstract][Full Text] [Related]
25. Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature. Labowitz J; Finklestein S; Rabinovitz M Am J Gastroenterol; 2001 Apr; 96(4):1274-7. PubMed ID: 11316183 [TBL] [Abstract][Full Text] [Related]
26. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. Kadlub N; Vazquez MP; Galmiche L; L'Herminé AC; Dainese L; Ulinski T; Fauroux B; Pavlov I; Badoual C; Marlin S; Deckert M; Leboulanger N; Berdal A; Descroix V; Picard A; Coudert AE J Bone Miner Res; 2015 May; 30(5):878-85. PubMed ID: 25491283 [TBL] [Abstract][Full Text] [Related]
27. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients. Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701 [TBL] [Abstract][Full Text] [Related]
30. Postinfantile giant cell hepatitis associated with long-term elevated transaminase levels in treated Graves' disease. Harrison RA; Bahar A; Payne MM Am J Med; 2002 Mar; 112(4):326-7. PubMed ID: 11893377 [No Abstract] [Full Text] [Related]
31. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India. Agarwal SK; Bhowmik D; Mahajan S; Bagchi S Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825 [TBL] [Abstract][Full Text] [Related]
32. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report. Oya H; Sato Y; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K Transplant Proc; 2009; 41(1):433-4. PubMed ID: 19249573 [TBL] [Abstract][Full Text] [Related]
33. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis. Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162 [TBL] [Abstract][Full Text] [Related]
34. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Grigg SE; Sarri GL; Gow PJ; Yeomans ND Aliment Pharmacol Ther; 2019 May; 49(10):1260-1273. PubMed ID: 30989721 [TBL] [Abstract][Full Text] [Related]
35. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial. Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759 [TBL] [Abstract][Full Text] [Related]
36. Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature. Rhodes JM; Schuster SJ; Furth EE; Kennard K; Nasta SD; Svoboda J; Porter DL; Mato AR Cancer Biol Ther; 2019; 20(8):1136-1140. PubMed ID: 31091174 [TBL] [Abstract][Full Text] [Related]
37. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Penninga L; Wettergren A; Chan AW; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008852. PubMed ID: 22419339 [TBL] [Abstract][Full Text] [Related]
38. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. Duvoux C; Villamil F; Renner EL; Grazi GL; Firpi RJ; Pageaux G; Mulhaupt B; Schirm F; Rauer B; Bernhardt P; Levy G Ann Transplant; 2015 Jan; 20():25-35. PubMed ID: 25588713 [TBL] [Abstract][Full Text] [Related]
39. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial. El-Hamamsy M; Montasser IF; Mansy AE; Nabet DE; El-Meteini M J Clin Pharm Ther; 2019 Jun; 44(3):447-453. PubMed ID: 30714175 [TBL] [Abstract][Full Text] [Related]
40. Calcineurin inhibitors in renal transplantation: what is the best option? Tanabe K Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]